U.S. Top Stock Picks from Analysts

Regeneron Pharmaceuticals

Market Cap: US$57.9b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Marvell Technology

Market Cap: US$49.9b

Provides data infrastructure semiconductor solutions, spanning the data center core to network edge.

JD.com

Market Cap: US$49.1b

Operates as a supply chain-based technology and service provider in the People’s Republic of China.

Venture Global

Market Cap: US$22.2b

Engages in the development, construction, and production of natural gas liquefaction and export projects near the U.S.

Summit Therapeutics

Market Cap: US$18.3b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

BioMarin Pharmaceutical

Market Cap: US$11.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

FTAI Aviation

Market Cap: US$11.3b

Owns, acquires, and sells aviation equipment for the transportation of goods and people worldwide.

Globus Medical

Market Cap: US$9.8b

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Sociedad Química y Minera de Chile

Market Cap: US$9.8b

Operates as a mining company worldwide.

Moderna

Market Cap: US$9.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

VinFast Auto

Market Cap: US$8.6b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

AST SpaceMobile

Market Cap: US$8.3b

Designs and develops the constellation of BlueBird satellites in the United States.

Roivant Sciences

Market Cap: US$7.9b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Revolution Medicines

Market Cap: US$7.8b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Corcept Therapeutics

Market Cap: US$7.6b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

UWM Holdings

Market Cap: US$6.7b

Engages in the origination, sale, and servicing residential mortgage lending in the United States.

BridgeBio Pharma

Market Cap: US$6.6b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Onto Innovation

Market Cap: US$6.2b

Engages in the design, development, manufacture, and support of process control tools that performs optical metrology and inspection worldwide.

Jazz Pharmaceuticals

Market Cap: US$6.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Legend Biotech

Market Cap: US$5.9b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Caesars Entertainment

Market Cap: US$5.8b

Operates as a gaming and hospitality company.

Lantheus Holdings

Market Cap: US$5.6b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Axsome Therapeutics

Market Cap: US$5.4b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

GDS Holdings

Market Cap: US$5.3b

Develops and operates data centers in the People's Republic of China.

V.F

Market Cap: US$5.2b

Engages in the design, procurement, marketing, and distribution of branded lifestyle apparel, footwear, and accessories for men, women, and children in the Americas, Europe, and the Asia-Pacific.

Ionis Pharmaceuticals

Market Cap: US$5.2b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Nuvalent

Market Cap: US$5.1b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Americold Realty Trust

Market Cap: US$4.9b

Americold is a global leader in temperature-controlled logistics real estate and value added services.

ChampionX

Market Cap: US$4.8b

Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.

BGC Group

Market Cap: US$4.5b

Operates as a financial brokerage and technology company in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

Icahn Enterprises

Market Cap: US$4.5b

Through its subsidiaries engages in the investment, energy, automotive, food packaging, real estate, home fashion and pharma in the United States and internationally.

Tower Semiconductor

Market Cap: US$4.2b

An independent semiconductor foundry, provides technology, development and process platforms for integrated circuits in the United States, Japan, Asia, and Europe.

Copa Holdings

Market Cap: US$4.2b

Through its subsidiaries, provides airline passenger and cargo services.

Vaxcyte

Market Cap: US$4.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Krystal Biotech

Market Cap: US$4.0b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Cytokinetics

Market Cap: US$3.9b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.